Research map: Artemisinin liposomes regulates breast cancer metastasis and apoptosis through TIGIT/CD155 signal axis

Back to the article

Papers in this map

  1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries · Hyuna Sung · 2021 · 114646 citations · Cited by this paper
  2. The autoimmune regulator (AIRE) is a target of the E3-Ubiquitin ligase Seven-in-absentia homolog 1 (SIAH1). · 2026 · Related
  3. Breast Cancer Treatment · Adrienne Gropper Waks · 2019 · 5019 citations · Cited by this paper
  4. PSD3 links autophagic flux to MHC-I–associated immune modulation in esophageal squamous cell carcinoma · 2026 · Related
  5. Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation · Mark E. Robson · 2017 · 3330 citations · Cited by this paper
  6. Taginostat, a new quinolone-based HDAC6 inhibitor, promotes apoptosis of chronic lymphocytic leukemia cells in vitro and in vivo by activating STAT4 · 2026 · Related
  7. Breast cancer statistics, 2019 · Carol E. Desantis · 2019 · 3238 citations · Cited by this paper
  8. H4K8 lactylation-mediated ferroptosis defense drives EGFR-TKI resistance in lung adenocarcinoma · 2026 · Related
  9. PARP inhibitors: Synthetic lethality in the clinic · Christopher J. Lord · 2017 · 2989 citations · Cited by this paper
  10. A novel ZNF263-SMOX-ROS-TRIB3 signaling axis drives Wnt/β-catenin activation and metastatic progression in colorectal cancer · 2026 · Related
  11. Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade · Brian C. Miller · 2019 · 2185 citations · Cited by this paper
  12. Microglial tunneling nanotubes: an intercellular transfer facilitating mitochondrial dysfunction and neuroinflammation in experimental cerebral malaria · 2026 · Related
  13. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design · Thomas A. Waldmann · 2006 · 1184 citations · Cited by this paper
  14. Retiring M1/M2: a view from the succinate receptor · 2026 · Related
  15. Mechanisms Controlling PD-L1 Expression in Cancer · Jong‐Ho Cha · 2019 · 1098 citations · Cited by this paper
  16. Identifying Neddylation-modified features to assess prognosis and immune efficacy in hepatocellular carcinoma · 2026 · Related
  17. TIGIT in cancer immunotherapy · Joë-Marc Chauvin · 2020 · 814 citations · Cited by this paper
  18. Apoptotic bodies in bone homeostasis and skeletal disease: biology and therapeutic implications · 2026 · Related
  19. Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science · Yuening Xiang · 2019 · 777 citations · Cited by this paper
  20. A pH-responsive silver nanoparticle platform overcomes MEK inhibitor resistance in neurofibroma via triacsin C-mediated lipid metabolic reprogramming · 2026 · Related
  21. Drug repurposing: a promising tool to accelerate the drug discovery process · Vineela Parvathaneni · 2019 · 597 citations · Cited by this paper
  22. TIGIT as an emerging immune checkpoint · Heidi Harjunpää · 2019 · 570 citations · Cited by this paper
  23. Resveratrol for cancer therapy: Challenges and future perspectives · Boxu Ren · 2021 · 494 citations · Cited by this paper
  24. Artemisinins: their growing importance in medicine · Sanjeev Krishna · 2008 · 394 citations · Cited by this paper
  25. Drug repurposing in cancer · Linda Sleire · 2017 · 339 citations · Cited by this paper
  26. Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530 · Tim P. Green · 2009 · 260 citations · Cited by this paper
  27. Targeting Src in breast cancer · Richard S. Finn · 2008 · 246 citations · Cited by this paper
  28. Functional Network Pipeline Reveals Genetic Determinants Associated with in Situ Lymphocyte Proliferation and Survival of Cancer Patients · Bernhard Mlecnik · 2014 · 231 citations · Cited by this paper
  29. Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy · Shoubao Ma · 2022 · 230 citations · Cited by this paper
  30. CD 155, an onco‐immunologic molecule in human tumors · Jian Gao · 2017 · 205 citations · Cited by this paper
  31. The potential and promise of IL-15 in immuno-oncogenic therapies · Tanya O. Robinson · 2017 · 199 citations · Cited by this paper
  32. Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530 · Y-M Chang · 2008 · 188 citations · Cited by this paper
  33. FDA Approval Summary: Atezolizumab Plus Paclitaxel Protein-bound for the Treatment of Patients with Advanced or Metastatic TNBC Whose Tumors Express PD-L1 · Preeti Narayan · 2020 · 187 citations · Cited by this paper
  34. Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for “on-demand” drug delivery · Ying Qu · 2019 · 165 citations · Cited by this paper
  35. Chemopreventive and therapeutic potential of curcumin in esophageal cancer: Current and future status · AmirReza Hesari · 2018 · 131 citations · Cited by this paper
  36. Celastrol in cancer therapy: Recent developments, challenges and prospects · Hannah Ying Lim · 2021 · 123 citations · Cited by this paper
  37. The IL-15–AKT–XBP1s signaling pathway contributes to effector functions and survival in human NK cells · Yufeng Wang · 2018 · 118 citations · Cited by this paper
  38. Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer · Tina Cascone · 2021 · 113 citations · Cited by this paper
  39. CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma · Kyle B. Lupo · 2020 · 111 citations · Cited by this paper

Source: OpenAlex (CC0)